Leaderboards/Bone Tumor Diagnosis and Treatments

Bone Tumor Diagnosis and Treatments

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Maartje E. Meier
Leiden University Medical Center
2
Myrsini Ioakeim‐Ioannidou
Harvard University
3
Claudia Deckers
Radboud University Nijmegen
4
Jiuhui Xu
Peking University
5
Xulei Huo
National Clinical Research Center for Digestive Diseases
6
Tony G. Kleijn
University of Groningen
7
Maria Vittoria Colombo
Ente Ospedaliero Cantonale
8
Emel Rothzerg
The University of Western Australia
9
Fátima Álvarez Jáñez
Hospital Universitario Virgen del Rocío
10
Tomoya Masunaga
Nara Medical University

Papers

1
Incidence and Prevalence of Fibrous Dysplasia/McCune-Albright Syndrome: A Nationwide Registry-Based Study in Denmark
The Journal of Clinical Endocrinology & Metabolism|2024
27 cit.
2
Publication in Seminars in Radiation Oncology (2024) [10 citations, W4392900148]
Seminars in Radiation Oncology|2024
10 cit.
3
Publication in The American Journal of Surgical Pathology (2024) [8 citations, W4402576981]
The American Journal of Surgical Pathology|2024
8 cit.
4
Publication in International Journal of Radiation Oncology*Biology*Physics (2024) [8 citations, W4402623821]
International Journal of Radiation Oncology*Biology*Physics|2024
8 cit.
5
Publication in Modern Pathology (2025) [8 citations, W4406755716]
Modern Pathology|2025
8 cit.
6
Publication in Genes Chromosomes and Cancer (2025) [4 citations, W4408922399]
Genes Chromosomes and Cancer|2025
4 cit.
7
Publication in Pediatric Blood & Cancer (2024) [2 citations, W4392296781]
Pediatric Blood & Cancer|2024
2 cit.
8
Publication in International Journal of Radiation Oncology*Biology*Physics (2025) [2 citations, W4409263900]
International Journal of Radiation Oncology*Biology*Physics|2025
2 cit.
9
Neutrophil elastase promotes low molecular weight cyclin E1 formation to accelerate osteosarcoma proliferation
Frontiers in Immunology|2025
2 cit.
10
Publication in Neuro-Oncology (2025) [2 citations, W4417524765]
Neuro-Oncology|2025
2 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Alison M. Boyce
National Institutes of Health
2
Fitim Berisha
Royal National Orthopaedic Hospital
3
Sean P Turner
Wisconsin Elks Association
4
Jan Demol
Transport & Mobility Leuven (Belgium)
5
Sakiko Soutome
Toyama University Hospital
6
HW Bart Schreuder
Radboud University Nijmegen
7
Yazhuo Zhang
Beijing Institute of Neurosurgery
8
Ricardo Delgado‐Chávez
Universidad Nacional Autónoma de México
9
David R. Raleigh
University of California, San Francisco
10
Patrick Randolph‐Quinney
University of the Witwatersrand

Papers

1
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities
Nature Genetics|2022
302 cit.
2
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
Nature Medicine|2023
106 cit.
3
Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features
Neuro-Oncology|2022
71 cit.
4
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution
Nature Genetics|2024
55 cit.
5
Radiotherapy and radiosurgery for meningiomas
Neuro-Oncology Advances|2023
36 cit.
6
Intratumor and informatic heterogeneity influence meningioma molecular classification
Acta Neuropathologica|2022
33 cit.
7
Environmentally Toxic Solid Nanoparticles in Noradrenergic and Dopaminergic Nuclei and Cerebellum of Metropolitan Mexico City Children and Young Adults with Neural Quadruple Misfolded Protein Pathologies and High Exposures to Nano Particulate Matter
Toxics|2022
32 cit.
8
Epigenetic reprogramming shapes the cellular landscape of schwannoma
Nature Communications|2024
29 cit.
9
Identification of <scp> <i>GNAS</i> </scp> Variants in Circulating <scp>Cell‐Free DNA</scp> from Patients with Fibrous Dysplasia/ <scp>McCune</scp> Albright Syndrome
Journal of Bone and Mineral Research|2023
26 cit.
10
Perivascular NOTCH3+ Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy
Cancer Discovery|2024
24 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Adrienne M. Flanagan
Royal National Orthopaedic Hospital
2
Michael T. Collins
National Institutes of Health
3
Pancras C.W. Hogendoorn
Vrije Universiteit Brussel
4
Judith V.M.G. Bovée
Leiden University Medical Center
5
Fredrik Mertens
Lund University
6
Piero Picci
Istituto Ortopedico Rizzoli
7
Christopher D.�M. Fletcher
Brigham and Women's Hospital
8
Alberto G. Ayala
The University of Texas MD Anderson Cancer Center
9
R. J. Grimer
Royal Orthopaedic Hospital
10
Constantine A. Stratakis
Institute of Molecular Biology and Biotechnology

Papers

1
World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone
Lund University Publications (Lund University)|2002
2.8k cit.
2
Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complex
Nature Genetics|2000
1.1k cit.
3
<i>IDH1</i> and <i>IDH2</i> mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
The Journal of Pathology|2011
994 cit.
4
Inflammatory Myofibroblastic Tumor
The American Journal of Surgical Pathology|2007
972 cit.
5
Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone
Nature Genetics|2013
853 cit.
6
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology|2010
718 cit.
7
Adjuvant Chemotherapy for Adult Soft Tissue Sarcomas of the Extremities and Girdles: Results of the Italian Randomized Cooperative Trial
Journal of Clinical Oncology|2001
710 cit.
8
Atypical and Malignant Solitary Fibrous Tumors in Extrathoracic Locations
The American Journal of Surgical Pathology|1998
649 cit.
9
Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking <i>KIT</i> and <i>PDGFRA</i> mutations
Proceedings of the National Academy of Sciences|2010
611 cit.
10
Loss of INI1 Expression is Characteristic of Both Conventional and Proximal-type Epithelioid Sarcoma
The American Journal of Surgical Pathology|2009
600 cit.

Reagents for Bone Tumor Diagnosis and Treatments

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 66

Sox9 (D8G8H) Rabbit Monoclonal Antibody

#82630$159,886
View Evidence →
Cell Signaling TechnologyEvidence 65

Goat Anti-Mouse IgG1 Antibody (Alexa Fluor® 647 Conjugate)

#92228$313
View Evidence →
Cell Signaling TechnologyEvidence 65

CYLD (D1A10) Rabbit Monoclonal Antibody

#8462$152,351
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 66

Phospho-Stat6 (Tyr641) (D8S9Y) Rabbit Monoclonal Antibody (SignalFlex™ Alexa Fluor® 350 Conjugate)

#71190$486
View Evidence →
Abcam

GABA B Receptor 1 antibody

#S1002
View Evidence →
Agilent/DakoEvidence 60

EnVision FLEX /HRP

#SM802
View Evidence →